2021
Prevalence and significance of M541L single nucleotide polymorphism in the central European cohort of gastrointestinal stromal tumor patients
JASEK, Karin, Marian GRENDAR, Andrea STANCLOVA, Bibiana MALICHEROVA, Ivana KASUBOVA et. al.Základní údaje
Originální název
Prevalence and significance of M541L single nucleotide polymorphism in the central European cohort of gastrointestinal stromal tumor patients
Autoři
JASEK, Karin, Marian GRENDAR (703 Slovensko), Andrea STANCLOVA (703 Slovensko), Bibiana MALICHEROVA (703 Slovensko), Ivana KASUBOVA (703 Slovensko), Tatiana BURJANIVOVA (703 Slovensko), Peter SZEPE (703 Slovensko), Rachele CICCOCIOPPO (380 Itálie), Luis RODRIGO (724 Španělsko), Robert PROSECKÝ (203 Česká republika, domácí), Peter KRUŽLIAK (703 Slovensko), Lukas PLANK (703 Slovensko) a Zora LASABOVA (703 Slovensko)
Vydání
Journal of cancer research and clinical oncology, Germany, Springer-Verlag, 2021, 0171-5216
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30204 Oncology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 4.322
Kód RIV
RIV/00216224:14110/21:00120776
Organizační jednotka
Lékařská fakulta
UT WoS
000577037900001
Klíčová slova anglicky
Gastrointestinal stromal tumors; Single nucleotide polymorphism; c; 1621 A > C; M541L; c-KIT
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 8. 4. 2021 11:00, Mgr. Tereza Miškechová
Anotace
V originále
Background Single nucleotide polymorphisms can create a genetic microenvironment in some tumors that affects the course of treatment, resistance, etc. Whether single nucleotide polymorphisms have an impact on gastrointestinal stromal tumor (GIST) development and disease progression is not yet accurately verified.KITSNP(M541L)in exon 10 correlates with a worse prognosis of many cancers. The impact ofKITSNP(M541L)in GISTs is relatively unknown and, therefore, its analyses could have potential in patient therapy and could provide more detailed information on tumor character, clinical presentation, or tumor behavior in treatment. Aim The aim of the study was the analysis of the biological and clinical significance of theKITSNP(M541L)polymorphism in exon 10. Materials and methods Paraffin sample tissues were obtained from the National GIST Register in Martin. Retrospective samples from 177 GIST patients were divided into several groups. Detection of SNP(M541L)was performed by Sanger sequencing. Statisitical analyses were performed to determine the prevalence ofKITSNP(M541L)in the Slovak GIST cohort, to search for correlation betweenc-KITstatus and clinicopathological, molecular and biological data. Results Overall, 29 samples out of 177 showedKITSNP(M541L)polymorphism. Conclusion Our results do not support the association betweenKITSNP(M541L)and increased risk of relapse in localized primary GISTs. Additionally, we found a positive correlation betweenKITSNP(M541L)occurrence and earlier onset of relapse inPDGFRaand WT subgroup of GISTs.